Warning: The NCBI web site requires JavaScript to function. more...
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.
Diabetes. 2002 Jun;51(6):1949-56.PMID: 12031985 [PubMed - indexed for MEDLINE]Related articlesFree article
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.
Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article
Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetologia. 2003 May;46(5):674-82. Epub 2003 May 13.PMID: 12743701 [PubMed - indexed for MEDLINE]Related articles
Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.
Magkos F, Mohammed BS, Mittendorfer B.
Int J Obes (Lond). 2008 Nov;32(11):1655-64. Epub 2008 Sep 9.PMID: 18779822 [PubMed - indexed for MEDLINE]Related articlesFree article
Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ.
Clin Chem. 2004 Jul;50(7):1189-200. Epub 2004 Apr 23.PMID: 15107310 [PubMed - indexed for MEDLINE]Related articlesFree article
Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA.
Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1046-53.PMID: 9672064 [PubMed - indexed for MEDLINE]Related articlesFree article
Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCCT/EDIC Research Group.
Kidney Int. 2003 Sep;64(3):817-28.PMID: 12911531 [PubMed - indexed for MEDLINE]Related articles
Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA.
Am J Cardiol. 2002 Oct 17;90(8A):71i-76i.PMID: 12419483 [PubMed - indexed for MEDLINE]Related articles
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
Soedamah-Muthu SS, Colhoun HM, Thomason MJ, Betteridge DJ, Durrington PN, Hitman GA, Fuller JH, Julier K, Mackness MI, Neil HA; CARDS Investigators.
Atherosclerosis. 2003 Apr;167(2):243-55.PMID: 12818407 [PubMed - indexed for MEDLINE]Related articles
Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCC/EDIC Research Group.
Diabetes Care. 2003 Mar;26(3):810-8.PMID: 12610042 [PubMed - indexed for MEDLINE]Related articlesFree article
Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
Arch Intern Med. 2005 Mar 14;165(5):510-5.PMID: 15767525 [PubMed - indexed for MEDLINE]Related articlesFree article
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT; DCCT/EDIC Research Group.
Diabet Med. 2006 Sep;23(9):955-66.PMID: 16922701 [PubMed - indexed for MEDLINE]Related articles
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):910-8.PMID: 14985310 [PubMed - indexed for MEDLINE]Related articlesFree article
Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes.
Colhoun HM, Taskinen MR, Otvos JD, Van Den Berg P, O'Connor J, Van Tol A.
Diabetes. 2002 Nov;51(11):3300-5.PMID: 12401722 [PubMed - indexed for MEDLINE]Related articlesFree article
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
Atherosclerosis. 2002 Aug;163(2):287-96.PMID: 12052475 [PubMed - indexed for MEDLINE]Related articles
Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT; DCCT/EDIC Research Group.
Metabolism. 2004 Oct;53(10):1296-304.PMID: 15375785 [PubMed - indexed for MEDLINE]Related articles
Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
Siegel RD, Cupples A, Schaefer EJ, Wilson PW.
Metabolism. 1996 Oct;45(10):1267-72.PMID: 8843183 [PubMed - indexed for MEDLINE]Related articles
Women have a larger and less atherogenic low density lipoprotein particle size than men.
Nikkilä M, Pitkäjärvi T, Koivula T, Solakivi T, Lehtimäki T, Laippala P, Jokela H, Lehtomäki E, Seppä K, Sillanaukee P.
Atherosclerosis. 1996 Jan 26;119(2):181-90.PMID: 8808495 [PubMed - indexed for MEDLINE]Related articles
Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
Bavirti S, Ghanaat F, Tayek JA.
Endocr Pract. 2003 Nov-Dec;9(6):487-93.PMID: 14715475 [PubMed - indexed for MEDLINE]Related articles
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T.
Diabetes. 2008 Aug;57(8):2022-7. Epub 2008 May 9.PMID: 18469202 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...